Use of antibody drug conjugate
TW202629261APending Publication Date: 2026-07-16DAIICHI SANKYO CO LTD +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114147946
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2013-12-25
- Filing Date
- 2014-12-25
- Publication Date
- 2026-07-16
Abstract
The invention provides an antitumor drug with excellent antitumor efficacy and safety profile, exhibiting superior therapeutic effects. An anti-TROP2 antibody is provided, comprising: CDRH1 composed of an amino acid sequence of sequence identification number 23, CDRH2 composed of an amino acid sequence of sequence identification number 24, and CDRH3 composed of an amino acid sequence of sequence identification number 25 in the variable region of its heavy chain; and CDRL1 composed of an amino acid sequence of sequence identification number 26, CDRL2 composed of an amino acid sequence of sequence identification number 27, and CDRL3 composed of an amino acid sequence of sequence identification number 28 in the variable region of its light chain.
Need to check novelty before this filing date? Find Prior Art